Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 16 | 0 | 2 | 0 | €96.11 | €116.81 | 21.535% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €84.60 | €100.00 | 18.203% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €67.00 | €100.00 | 49.254% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €71.50 | €100.00 | 39.860% |
| Sanofi S.A. | 5 | 0 | 1 | 0 | €91.45 | €99.50 | 8.803% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.52 | €86.77 | 38.789% |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €55.00 | €85.64 | 55.715% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €61.00 | €79.55 | 30.417% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €52.74 | €78.42 | 48.696% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 1 | 0 | €64.00 | €74.65 | 16.633% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €38.10 | €70.00 | 83.727% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €22.60 | €68.78 | 204.333% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.90 | €65.00 | -4.271% |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.37 | €63.93 | 16993.850% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €23.79 | €60.55 | 154.536% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €51.71 | €55.00 | 6.362% |
| Celldex Therapeutics | 10 | 1 | 1 | 0 | €37.20 | €51.25 | 37.758% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.50 | €50.33 | 24.278% |
| Bayer AG | 15 | 1 | 1 | 0 | €29.31 | €50.00 | 70.619% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.60 | €50.00 | 26.263% |
| Novavax Inc. | 6 | 2 | 4 | 1 | €12.42 | €49.80 | 300.805% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €28.00 | €47.53 | 69.743% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |